{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:18:55Z","timestamp":1792459135374,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011132","name":"Rutgers, The State University of New Jersey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.smrv.2026.102246","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:09:33Z","timestamp":1769792973000},"page":"102246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pharmacologic treatment data from chronic insomnia studies and the application to individuals with acute insomnia, a narrative review"],"prefix":"10.1016","volume":"86","author":[{"given":"Andrew","family":"Krystal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Benca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William V.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Perlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel F.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Winkelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0014-4445","authenticated-orcid":false,"given":"Matt","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2026.102246_bib1","series-title":"Sleep difficulties in adults: united States, 2020","author":"Adjaye-Gbewonyo","year":"2022"},{"key":"10.1016\/j.smrv.2026.102246_bib2","series-title":"The international classification of sleep disorders","year":"2014"},{"key":"10.1016\/j.smrv.2026.102246_bib4","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"10","key":"10.1016\/j.smrv.2026.102246_bib5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jpsychires.2012.07.001","article-title":"The natural history of insomnia: focus on prevalence and incidence of acute insomnia","volume":"46","author":"Ellis","year":"2012","journal-title":"J Psychiatr Res"},{"issue":"6","key":"10.1016\/j.smrv.2026.102246_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz299","article-title":"The natural history of insomnia: the incidence of acute insomnia and subsequent progression to chronic insomnia or recovery in good sleeper subjects","volume":"43","author":"Perlis","year":"2020","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsmc.2022.03.003","article-title":"Epidemiology of insomnia: prevalence, course, risk factors, and public health burden","volume":"17","author":"Morin","year":"2022","journal-title":"Sleep Med Clin"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/smrv.2002.0186","article-title":"Epidemiology of insomnia: what we know and what we still need to learn","volume":"6","author":"Ohayon","year":"2002","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2026.102246_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.smrv.2018.10.006","article-title":"Insomnia as a predictor of mental disorders: a systematic review and meta-analysis","volume":"43","author":"Hertenstein","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jsr.12102","article-title":"Insomnia as a risk factor for ill health: results from the large population-based prospective HUNT study in Norway","volume":"23","author":"Sivertsen","year":"2014","journal-title":"J Sleep Res"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1207\/S15402010BSM0104_5","article-title":"Insomnia as a health risk factor","volume":"1","author":"Taylor","year":"2003","journal-title":"Behav Sleep Med"},{"issue":"6","key":"10.1016\/j.smrv.2026.102246_bib12","first-page":"971","article-title":"Treating acute insomnia: a randomized controlled trial of a \u201csingle-shot\u201d of cognitive behavioral therapy for insomnia","volume":"38","author":"Ellis","year":"2015","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jsmc.2019.01.007","article-title":"Cognitive behavioral therapy for insomnia and acute insomnia: considerations and controversies","volume":"14","author":"Ellis","year":"2019","journal-title":"Sleep Med Clin"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10020071","article-title":"Acute and chronic insomnia: what has time And\/or hyperarousal got to Do with it?","volume":"10","author":"Vargas","year":"2020","journal-title":"Brain Sci"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib15","first-page":"541","article-title":"A behavioral perspective on insomnia treatment","volume":"10","author":"Spielman","year":"1987","journal-title":"Psychiatr Clin"},{"key":"10.1016\/j.smrv.2026.102246_bib16","series-title":"Principles and practice of sleep medicine","first-page":"835","article-title":"Etiology and pathophysiology of insomnia","author":"Perlis","year":"2022"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ddmod.2011.07.002","article-title":"A neurobiological model of insomnia","volume":"8","author":"Buysse","year":"2011","journal-title":"Drug Discov Today Dis Model"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.smrv.2006.03.002","article-title":"The attention-intention-effort pathway in the development of psychophysiologic insomnia: a theoretical review","volume":"10","author":"Espie","year":"2006","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cpr.2005.04.005","article-title":"Cognitive approaches to insomnia","volume":"25","author":"Harvey","year":"2005","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.smrv.2026.102246_bib20","series-title":"Behavioral treatments for sleep disorders","first-page":"119","article-title":"Cognitive therapy for dysfunctional beliefs about sleep and insomnia","author":"Morin","year":"2011"},{"issue":"3","key":"10.1016\/j.smrv.2026.102246_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2869.1997.00045.x","article-title":"Psychophysiological insomnia: the behavioural model and a neurocognitive perspective","volume":"6","author":"Perlis","year":"1997","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2026.102246_bib22","series-title":"Principles and practice of sleep medicine","article-title":"Etiology and pathophysiology of insomnia","author":"Perlis","year":"2016"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae034","article-title":"The natural history of insomnia: evaluating illness severity from acute to chronic insomnia; is the first the worst?","volume":"47","author":"Boyle","year":"2024","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3999(02)00547-0","article-title":"On the comparability of pharmacotherapy and behavior therapy for chronic insomnia. Commentary and implications","volume":"54","author":"Perlis","year":"2003","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.smrv.2011.02.002","article-title":"Acute insomnia: current conceptualizations and future directions","volume":"16","author":"Ellis","year":"2012","journal-title":"Sleep Med Rev"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib26","first-page":"859","article-title":"Dose effects of temazepam in transient insomnia","volume":"40","author":"Roehrs","year":"1990","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/sleep\/18.4.246","article-title":"Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo","volume":"18","author":"Roth","year":"1995","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sleep.2004.09.001","article-title":"An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults","volume":"6","author":"Rosenberg","year":"2005","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.sleep.2008.04.010","article-title":"The effects of ramelteon in a first-night model of transient insomnia","volume":"10","author":"Zammit","year":"2009","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.smrv.2026.102246_bib30","first-page":"303","article-title":"Ramelteon (TAK-375), a selective MT1\/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment","volume":"28","author":"Roth","year":"2005","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hup.238","article-title":"Comparative efficacy of zolpidem and temazepam in transient insomnia","volume":"16","author":"Erman","year":"2001","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"10.1016\/j.smrv.2026.102246_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/clpt.1986.182","article-title":"Dose-related effects of triazolam and flurazepam on a circadian rhythm insomnia","volume":"40","author":"Seidel","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.smrv.2026.102246_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.sleep.2010.07.006","article-title":"Efficacy and safety of doxepin 6 mg in a model of transient insomnia","volume":"11","author":"Roth","year":"2010","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5664\/jcsm.26859","article-title":"Efficacy and tolerability of indiplon in transient insomnia","volume":"3","author":"Rosenberg","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0952-8180(97)00236-5","article-title":"Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery","volume":"9","author":"Morgan","year":"1997","journal-title":"J Clin Anesth"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/0269881111421971","article-title":"Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia","volume":"26","author":"Dijk","year":"2012","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004714-199504000-00009","article-title":"Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem","volume":"15","author":"Cluydts","year":"1995","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib38","first-page":"29","article-title":"Insomnia: pharmacologic therapy","volume":"96","author":"Matheson","year":"2017","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00003088-200443040-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone","volume":"43","author":"Drover","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"13","key":"10.1016\/j.smrv.2026.102246_bib41","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2165\/00003495-200868130-00011","article-title":"Ramelteon: a review of its use in insomnia","volume":"68","author":"Simpson","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.smrv.2026.102246_bib42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","article-title":"The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases","volume":"11","author":"Wang","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0043-1768667","article-title":"Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis","volume":"81","author":"Rocha","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.smrv.2026.102246_bib44","series-title":"Silenor\u00ae (doxepin) tablets for oral use. Full prescribing information","year":"2010"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11200810-000000000-00000","article-title":"Low-dose doxepin in the treatment of insomnia","volume":"24","author":"Weber","year":"2010","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib118","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smrv.2012.08.001","article-title":"Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications","volume":"17","author":"Krystal","year":"2013","journal-title":"Sleep Med. Rev."},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/15402002.2022.2074996","article-title":"Beyond stress: altered sleep-wake patterns are a key behavioral risk factor for acute insomnia during times of crisis","volume":"21","author":"Meaklim","year":"2023","journal-title":"Behav Sleep Med"},{"issue":"10","key":"10.1016\/j.smrv.2026.102246_bib50","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/jclp.22000","article-title":"Transient insomnia versus chronic insomnia: a comparison study of sleep-related psychological\/behavioral characteristics","volume":"69","author":"Yang","year":"2013","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.smrv.2026.102246_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2021.05.014","article-title":"Enhanced anti-correlation between the dorsal attention and default-mode networks: a resting-state fMRI study of acute insomnia","volume":"467","author":"Yang","year":"2021","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smrv.2009.04.002","article-title":"The hyperarousal model of insomnia: a review of the concept and its evidence","volume":"14","author":"Riemann","year":"2010","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2026.102246_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.smrv.2014.06.001","article-title":"Doxepin for insomnia: a systematic review of randomized placebo-controlled trials","volume":"19","author":"Yeung","year":"2015","journal-title":"Sleep Med Rev"},{"issue":"7","key":"10.1016\/j.smrv.2026.102246_bib55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.clinthera.2011.05.092","article-title":"A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation","volume":"33","author":"Mansbach","year":"2011","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib56","article-title":"Double-blind evaluation of the efficacy and safety of temazepam in outpatients with insomnia","volume":"8","author":"Fillingim","year":"1979","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.smrv.2026.102246_bib57","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.281.11.991","article-title":"Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial","volume":"281","author":"Morin","year":"1999","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hup.216","article-title":"Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia","volume":"15","author":"Drake","year":"2000","journal-title":"Hum Psychopharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.smrv.2026.102246_bib59","first-page":"39","article-title":"Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs","volume":"5","author":"Elie","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib60","first-page":"679","article-title":"Multi-clinic double-blind comparison of triazolam (halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia","volume":"39","author":"Fabre","year":"1978","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib61","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004850-199400940-00004","article-title":"Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo","volume":"9","author":"Hajak","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib62","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/030006058000800513","article-title":"The efficacy of triazolam and chloral hydrate in geriatric insomniacs","volume":"8","author":"Piccione","year":"1980","journal-title":"J Int Med Res"},{"issue":"5\u20136","key":"10.1016\/j.smrv.2026.102246_bib63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/j.1552-4604.1977.tb04611.x","article-title":"Comparison of triazolam, flurazepam, and placebo as hypnotics in geriatric patients with insomnia","volume":"17","author":"Reeves","year":"1977","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib64","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0197-4580(85)90006-5","article-title":"Efficacy of a reduced triazolam dose in elderly insomniacs","volume":"6","author":"Roehrs","year":"1985","journal-title":"Neurobiol Aging"},{"issue":"Suppl 2","key":"10.1016\/j.smrv.2026.102246_bib65","first-page":"1","article-title":"A dose-range finding study of zopiclone in insomniac patients","volume":"5","author":"Nair","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/j.1552-4604.1990.tb03486.x","article-title":"Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in outpatients with insomnia","volume":"30","author":"Scharf","year":"1990","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib67","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cpt1975175573","article-title":"Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo","volume":"17","author":"Sunshine","year":"1975","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib68","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4088\/JCP.v60n0806","article-title":"Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon clinical study group","volume":"60","author":"Elie","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib69","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.v65n0816","article-title":"Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia","volume":"65","author":"Perlis","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib70","first-page":"192","article-title":"A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia","volume":"55","author":"Scharf","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib71","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/sleep\/23.8.1h","article-title":"Eight weeks of non-nightly use of zolpidem for primary insomnia","volume":"23","author":"Walsh","year":"2000","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.smrv.2026.102246_bib72","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","article-title":"Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia","volume":"26","author":"Krystal","year":"2003","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.smrv.2026.102246_bib73","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1185\/030079906X112741","article-title":"A polysomnography study of eszopiclone in elderly patients with insomnia","volume":"22","author":"McCall","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.smrv.2026.102246_bib74","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/sleep\/28.6.720","article-title":"A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia","volume":"28","author":"Scharf","year":"2005","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.smrv.2026.102246_bib75","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1185\/174234304X15174","article-title":"Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia","volume":"20","author":"Zammit","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib76","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/sleep\/30.8.959","article-title":"Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations","volume":"30","author":"Walsh","year":"2007","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.smrv.2026.102246_bib47","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.smrv.2026.102246_bib48","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","article-title":"Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia","volume":"30","author":"Roth","year":"2007","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.smrv.2026.102246_bib53","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/sleep\/33.11.1553","article-title":"Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia","volume":"33","author":"Krystal","year":"2010","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sleep.2005.09.004","article-title":"An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia","volume":"7","author":"Erman","year":"2006","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib78","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.sleep.2006.01.003","article-title":"Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia","volume":"7","author":"Roth","year":"2006","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib79","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1185\/030079907X178874","article-title":"A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia","volume":"23","author":"Roth","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"10.1016\/j.smrv.2026.102246_bib80","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.sleep.2008.09.010","article-title":"A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients","volume":"10","author":"Hajak","year":"2009","journal-title":"Sleep Med"},{"issue":"10","key":"10.1016\/j.smrv.2026.102246_bib81","first-page":"1359","article-title":"Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies","volume":"31","author":"Lankford","year":"2008","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5664\/jcsm.27707","article-title":"Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with primary insomnia: results from two randomized, controlled, 3-month studies","volume":"6","author":"Roth","year":"2010","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib83","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.sleep.2007.06.006","article-title":"Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial","volume":"9","author":"Walsh","year":"2008","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/sleep\/30.5.593","article-title":"The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia","volume":"30","author":"Walsh","year":"2007","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.smrv.2026.102246_bib85","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/sleep\/30.6.743","article-title":"Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study","volume":"30","author":"Scharf","year":"2007","journal-title":"Sleep"},{"issue":"7\u20138","key":"10.1016\/j.smrv.2026.102246_bib86","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.sleep.2006.12.006","article-title":"Efficacy and tolerability of indiplon in older adults with primary insomnia","volume":"8","author":"Walsh","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2026.102246_bib87","series-title":"Lunesta\u00ae (eszopiclone) tablets, for oral use. Full prescribing information","year":"2004"},{"key":"10.1016\/j.smrv.2026.102246_bib88","series-title":"Rozerem (ramelteon) tablets, for oral use. Full prescribing information. Lexington, MA: takeda Pharmaceuticals America","year":"2005"},{"key":"10.1016\/j.smrv.2026.102246_bib89","series-title":"Belsomra\u00ae (suvorexant) tablets, for oral use. Full prescribing information","year":"2014"},{"key":"10.1016\/j.smrv.2026.102246_bib90","series-title":"Dayvigo\u2122 (lemborexant) tablets, for oral use. Full prescribing information","year":"2019"},{"key":"10.1016\/j.smrv.2026.102246_bib91","series-title":"Quviviq (daridorexant) tablets, for oral use. Full prescribing information. Radnor, PA","year":"2022"},{"key":"10.1016\/j.smrv.2026.102246_bib92","series-title":"Restoril\u2122 (temazepam) capsules. Full prescribing information","year":"1981"},{"key":"10.1016\/j.smrv.2026.102246_bib93","series-title":"Halcion\u00ae (triazolam) tablets. Full prescribing information","year":"1982"},{"key":"10.1016\/j.smrv.2026.102246_bib94","series-title":"Ambien\u00ae (zolpidem tartrate) tablets. Full prescribing information","year":"1992"},{"key":"10.1016\/j.smrv.2026.102246_bib95","series-title":"Sonata\u00ae (zaleplon) capsules. Full prescribing information","year":"2004"},{"issue":"32","key":"10.1016\/j.smrv.2026.102246_bib96","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.2174\/138161208786549290","article-title":"Intermittent and long-term use of sedative hypnotics","volume":"14","author":"Perlis","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Clinical guidelines committee of the American college of P. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.smrv.2026.102246_bib98","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"Riemann","year":"2017","journal-title":"J Sleep Res"},{"issue":"8","key":"10.1016\/j.smrv.2026.102246_bib99","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881119855343","article-title":"British association for psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update","volume":"33","author":"Wilson","year":"2019","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib101","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13201","article-title":"Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: a systematic review and network meta-analysis","volume":"142","author":"Samara","year":"2020","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14088","article-title":"Comparative short-term safety and efficacy of hypnotics: a quantitative risk-benefit analysis","volume":"33","author":"Cheung","year":"2024","journal-title":"J Sleep Res"},{"issue":"5","key":"10.1016\/j.smrv.2026.102246_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa260","article-title":"Comparative efficacy and safety of hypnotics for insomnia in older adults: a systematic review and network meta-analysis","volume":"44","author":"Chiu","year":"2021","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13311-021-01013-w","article-title":"Effects of cannabinoids on sleep and their therapeutic potential for sleep disorders","volume":"18","author":"Kaul","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.smrv.2026.102246_bib104","article-title":"The state of sleep: understanding insomnia symptoms and treatments in US adults","author":"Fisher","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.smrv.2026.102246_bib105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.sleep.2024.09.044","article-title":"Prevalence of insomnia and use of sleep aids among adults in Canada","volume":"124","author":"Morin","year":"2024","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.smrv.2026.102246_bib107","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.6462","article-title":"Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content","volume":"13","author":"Erland","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib108","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s11096-017-0467-x","article-title":"Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep","volume":"39","author":"Abraham","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"11","key":"10.1016\/j.smrv.2026.102246_bib109","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.smrv.2026.102246_bib110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/acer.12006","article-title":"Alcohol and sleep I: effects on normal sleep","volume":"37","author":"Ebrahim","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10.1016\/j.smrv.2026.102246_bib111","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4082\/kjfm.2015.36.6.294","article-title":"The effects of alcohol on quality of sleep","volume":"36","author":"Park","year":"2015","journal-title":"Korean J Fam Med"},{"issue":"1","key":"10.1016\/j.smrv.2026.102246_bib112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5665\/sleep.3316","article-title":"The natural history of insomnia: acute insomnia and first-onset depression","volume":"37","author":"Ellis","year":"2014","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.smrv.2026.102246_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac149","article-title":"The natural history of insomnia: high sleep reactivity interacts with greater life stress to predict the onset of acute insomnia","volume":"45","author":"Walker","year":"2022","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2026.102246_bib114","unstructured":"National Health Service (NHS). Insomnia. Available at: https:\/\/www.nhs.uk\/conditions\/insomnia\/;[Accessed 12 January 2026]."},{"key":"10.1016\/j.smrv.2026.102246_bib115","unstructured":"Health Canada. Sleep aids \u2013 labelling standard,https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/applications-submissions\/guidance-documents\/nonprescription-drugs-labelling-standards\/sleep-aids.html;[Accessed 12 January 2026]."},{"key":"10.1016\/j.smrv.2026.102246_bib116","unstructured":"U.S. Food and Drug Administration. Over-the-Counter (OTC) monograph M010: nighttime sleep-aid drug products for over-the-counter human use.,https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/omuf\/monographs\/OTCMonograph_M010-NighttimeSleepAidDrugProductsforOTCHumanUse_09202021.pdf. [Accessed 12 January 2026]."},{"key":"10.1016\/j.smrv.2026.102246_bib117","article-title":"Mapping the insomnia patient journey in Europe and Canada","volume":"11","author":"O'Regan","year":"2023","journal-title":"Front Public Health"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079226000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079226000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:01:35Z","timestamp":1791406895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079226000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":116,"alternative-id":["S1087079226000183"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2026.102246","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic treatment data from chronic insomnia studies and the application to individuals with acute insomnia, a narrative review","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2026.102246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102246"}}